Hyderabad: Revenue minister Ponguleti Srinivas Reddy on Monday said that the controversial Dharani portal will be replaced by the Bhu Bharati in April. He said the Bhu Bharati Act will come into ...

Eminent social worker, and daughter of noted freedom fighters, Krishna Bharati, passed away in Hyderabad on Sunday, March 23. She was 92-years-old. Krishna Bharati breathed her last at her ...

Rabindranath Tagore-founded Visva-Bharati, the only Central University in West Bengal, has got a new full-time Vice-Chancellor after a long gap of 15 months. Agriculture scientist Probir Kumar ...

Filmmaker Vikram Bhatt recently reflected on how many of his films, including Ghulam and Awara Paagal Deewana, received an ‘A’ certification from the censor board. Speaking on the Cyrus Says ...

Prasar Bharati has signed a mega deal, possibly its biggest-ever media deal, with veteran editor, journalist and news anchor Sudhir Chaudhary for the much-anticipated revival of Doordarshan.

Ionis Pharmaceuticals (NASDAQ:IONS) has entered into a license agreement under which Sobi receives exclusive rights in countries outside the U.S., Canada and China to commercialize olezarsen as a ...

Sobi® (STO: SOBI), today announced a research collaboration involving a new Phase 2a clinical trial for Gamifant® (emapalumab) for the potential treatment of interferon-gamma (IFNγ)-driven sepsis (IDS ...

Hyderabad: YS Vijayamma informed the National Company Law Tribunal (NCLT), Hyderabad branch, that both her son Y.S. Jagan Mohan Reddy and his wife Bharati Reddy were misleading the tribunal.

Q: Is Awara Paagal Deewana Flop or Hit? A: The performance of Awara Paagal Deewana was Average. Q: What is the overall Box Office Collection of Awara Paagal Deewana? A:Awara Paagal Deewana ...

Owen Poole, a Certified Sleep Science Coach and proclaimed mattress expert, has been producing sleep video content in the wellness space for over three years. After earning his certification from ...

Sweden’s Sobi has kicked off a rolling biologics license application in the US for SEL-212, vying to become a new option for patients with refractory chronic gout that doesn’t respond to ...

Swedish Orphan Biovitrum (Sobi) has agreed a $1.7 billion merger deal to acquire CTI BioPharma and its recently-approved Vonjo drug for people with blood cancer myelofibrosis and severe ...